Mechanism
HER3 × ErbB4
Assets acting on this target.
- Class
- HER3-targeting antibody fused to NRG-1 EGF domain; selective ErbB4 agonist
- Notes
- audit finding #1650 (minor); source: https://clinicaltrials.gov/api/v2/studies/NCT06369298
Mechanism
Assets acting on this target.
1 of 1 assets